Home9966 • HKG
add
Alphamab Oncology
Previous close
$5.30
Day range
$5.18 - $5.44
Year range
$3.81 - $13.46
Market cap
5.01B HKD
Avg Volume
2.44M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 41.15M | -27.34% |
Operating expense | 129.47M | -12.08% |
Net income | -85.37M | 4.31% |
Net profit margin | -207.43 | -31.70% |
Earnings per share | — | — |
EBITDA | -84.26M | 9.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.41B | 4.21% |
Total assets | 2.14B | 0.92% |
Total liabilities | 465.00M | -16.94% |
Total equity | 1.67B | — |
Shares outstanding | 939.72M | — |
Price to book | 2.98 | — |
Return on assets | -11.62% | — |
Return on capital | -12.87% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -85.37M | 4.31% |
Cash from operations | -64.60M | 16.25% |
Cash from investing | 69.18M | -66.53% |
Cash from financing | -19.78M | 78.75% |
Net change in cash | -25.16M | -154.80% |
Free cash flow | -47.75M | 39.75% |
About
CEO
Founded
2008
Website
Employees
435